An uncertainty budget was constructed for the measurement of ethanol in blood by headspace gas chromatography. The uncertainty budget, covering the analytical range of ethanol concentrations up to 3.00 g/kg, included analytical uncertainty components, traceability uncertainty components, and effects caused by interindividual variation in blood water content. The analytical combined standard uncertainty was estimated from duplicate measurements of real samples and included contributions from headspace recovery, variation between columns, injection, repeatability of analytical signals, and statistical uncertainty of the calibration function. The traceability uncertainty was estimated in a sub-budget based on information about the calibrator and about the preparation of the aqueous standards. Two uncertainty components depended on the interindividual variation in blood water content. First, it caused uncertainty on the density of the blood, and second, it had an effect on the gas phase concentration of ethanol when doing the headspace sampling. These effects as well as their covariance were included in the uncertainty budget. For fresh blood samples, the analytical uncertainty was the dominating uncertainty component, accounting for approximately 90% of the variance. For blood samples collected 100 h postmortem, the interindividual variation in blood water content was the largest uncertainty component. It was demonstrated that subtracting a "safety margin" of 0.1 g/kg from the results was sufficient to keep the risk of committing a type 1 error below 0.1% in ethanol concentrations ranging up to 2 g/kg for fresh blood samples. This risk was higher for postmortem blood samples because of the higher uncertainty of measurement, but still less than approximately 1.4%.
Introduction
In laboratory medicine and in forensic medicine multiple or even a lone measurement of ethanol may be of huge impor-tance for a single individual, ks a matter of course, the measurement method used in such instances should be thoroughly validated and under constant supervision in a quality assurance program, preferably including both internal and external quality control. But even a result from a well-controlled method inevitably suffers from uncertainty, that is, a repeated measurement will almost never give the exact same value. Room can be made for this uncertainty of measurement by subtracting a "safety margin" from the result to ensure that, for example, the result does not exceed a limit value only because of random effects of the measurement. How large should this safety margin be? The answer depends both on the acceptable risk of committing a type 1 error and on the uncertainty of the result. The present paper deals with the latter problem, that is, the evaluation of uncertainty of measurement. Several examples of uncertainty evaluations with relevance to analytical chemistry have come to light since the first publication of the Guide to the Expression of Uncertainty in Measurement (GUM) in 1993 (1) . The method principles covered by examples include titration methods (2, 3) , high-performance liquid chromatography (HPLC) (4, 5) , atomic absorption spectrometry (6) , spectrophotometric methods (7) , and immunochemical methods (8, 9) . Although the collection of examples thus covers many methods, it is not easy to generalize the uncertainty evaluation procedure from them. Unless evaluation of uncertainty is to be reserved for reference methods and other chemical analyses of similar prominence, as suggested by some authors (10) , it is necessary to reduce the time it takes to evaluate uncertainty (11) . This can be done, for example, by systematically applying the same evaluation procedure for different analytical methods and by making use of information from method validation studies or participation in external quality control assessment schemes. In the Eurachem/CITAC guide Quantifying Uncertainty in Analytical Measurement (QUAM), validation data is proposed as a valuable source of input to the uncertainty calculation (12), but no principle is proposed for a systematic use of this information. A generic approach for evaluation of uncertainty based on the analytical uncertainty was suggested in 2001 (9) . This approach, named MODUS, was intended as a GUM-based strategy for evaluating the uncertainty of several types of analytical chemistry methods. At present, only immunochemical methods have been subjected to the MODUS approach (8, 9) . The primary aim of this paper was therefore to evaluate the uncertainty of the result of measurements of ethanol in whole blood by headspace gas chromatography (GC) based on the MODUS approach. The uncertainty was evaluated for both fresh blood samples (e.g., samples collected from living persons by the police in the course of investigating traffic violations) and blood samples collected postmortem. The second aim was to use the uncertainty budget to identify significant sources of uncertainty that may become targets for reducing the combined standard uncertainty. In particular, we are interested in characterizing the balance between analytical imprecision, uncertainty caused by biological variation, and uncertainty from the calibration. Lastly, we will use the uncertainty budget to investigate the distribution of measurement results that may be obtained on a sample with an ethanol concentration of 2.00 g/kg, which is an important legal limit in Denmark.
Methods

Instruments and reagents
Analyses were done using five headspace GCs (HS40 or HS40XL and GC Autosystem or GC XL Autosystem, PerkinElmer, Inc., Boston, MA) connected by a Turbochrom Client/server system (PerkinElmer, Inc.). NaF and I g/L NaN3 with ethanol concentrations 0.2, 0.5, 1.5, and 3.0 g/kg. Standards are prepared by weighing and diluting a pure ethanol solution (94.13 weight % determined by densitometry, certificate according to Ph.Eur 4th ed., Danisco Distillers, Aalborg, Denmark). The analytical balance used for weighing is traceable to the kilogram in the SI unit system. Volumetric equipment used for preparing the standards has been checked by weighing. Calibration standards are run every 2-3 weeks and after services on instruments. Dilution reagents containing internal standard: aqueous 2.5 g/L Na2SO3 with either 15 mg/L tert-butanol or 20 mg/L 2-butanol (Merck, Darmstadt, Germany) as internal standard. The dilution reagent is stable up to 5 days.
Analysis
Each blood sample is measured in duplicate. The duplicate analysis is made with different internal standards on different GCs. For analysis, I volume of blood is diluted with 10 volumes of dilution reagent.
Combination of uncertainty components
The analytical procedure is outlined in Figure 1 , where several uncertainty components are also given. The result of measurement is calculated as:
In this expression BAC is the blood-alcohol concentration (g/kg). The average density of blood, is a constant and cl and c2 are the concentrations of ethanol (expressed in g/L) in blood in test portion 1 and 2, respectively. Because c~ and c2 are obtained by measurement, the variation of their average is a measure of the analytical uncertainty. The use of two distinct GC instruments with independent calibrations (although the same calibrator is used) and independent internal standards, ensure that the analytical uncertainty includes uncertainty components from the calibration function (statistical uncertainty), preparation of internal standards, dilution, headspace sampling, different chromatographic columns, and differences in running conditions.
In order to account for uncertainty components other than the analytical uncertainty, Equation i is expanded to:
The meaning of the new terms is as follows: Traceability (ftrac)* The aqueous standards are prepared from a pure aqueous ethanol (the calibrator) by weighing. The uncertainty contributions from the concentration of the calibrator and from weighings cause correlated uncertainties between the concentrations of the aqueous standards. This correlated effect is corrected by the factor ftrac.
The density of blood (fdens). The correction factor fdens corrects for the error made by using the average density of blood instead of the actual density.
Interindividual variation in blood water content (fw). Ethanol in blood is not equally soluble in the aqueous and non-aqueous phase, and this may interfere with the headspace sampling (13) . The correction factor f~ expresses the correction the error made by assuming a constant water content of blood instead of taking the actual water content into account.
The uncertainty aspects of the sampling proces were not considered because sampling was not under control of the analytical laboratory. In other words, the uncertainty budget concerns a blood sample as it is received in the laboratory.
Assuming that the analytical standard uncertainty is the same for all GCs used, that is U(Cl) --u(c2) = u(c), the expression for the combined standard uncertainty is (1,9):
In this expression u(x) denote the standard uncertainty of the quantity x (that is, u(BAC) is the standard uncertainty of BAC, etc.), is the average of Cl and c2, n is the number of replicates (equal to 2 in the present case) and u(fdensfw) is the covariance between fdens and fw. The latter term is necessary because both fdens and fw depend on the water content. The water content depending terms in Eq. 3a can be grouped in a single term expressing the relative standard uncertainty associated with interindividual variability in the blood water content as
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and inserting this into Eq. 3a results in
Evaluation of the requirements to the combined standard uncertainty
Considering a situation where the result of a measurement of ethanol in blood, BAC, exceeds a limit value, LV, that is, BAC > LV. On this basis one wants to make inferences about the true concentration of ethanol in blood, IJethanoJ. The hypothesis is that Pethanol < LV, in other words, that the limit value is not exceeded. It seems obvious to reject the hypothesis since the result of measurement is larger than LV. However, because of the uncertainty of measurement, BAC will in general differ from lJetha,o,, and one can therefore not reject the hypothesis on safe statistical ground just because BAC > LV. To allow for this uncertainty of measurement, one will reject the hypothesis only ifBAC > LV+ d, where d is a "safety" margin. The probability of committing a type 1 error, that is, erroneously concluding that the limit value is exceeded, is a. In legal blood ethanol measurement, one wants a to be as small as practically possible. The probability a depends on IJethanol, and it is largest when Pethano, = LV. In this case, a is equal to the probability that the difference BAC-l~etha,ol will exceed d. The difference BACIJethanol divided with p(BAC) is equal to the deviation z in the standardized Gaussian distribution, that is: In other words, the maximum value of a is equal to the probability forz > d/u(BAC). In order to calculate limits for u(BAC) given values of a and d, Eq. 4 is rearranged to:
where za is the deviate for the probability a.
Results
Analytical standard uncertainty
The analytical standard uncertainty, that is, the standard uncertainty of (cl + c2)/2, was evaluated from statistical analysis of the duplicate measurements of real samples. Samples were grouped according to concentration in 0.25 g/kg intervals, and the analytical standard deviation was estimated from the pooled standard deviation between duplicates. A mathematical model for the analytical standard deviation was then fitted to the data:
where Sa is the analytical standard deviation of single measurements, and w is the weight fraction. The relative analytical standard deviation, CV = sa/w was used as the value ofu(c)/c in Equation 3 . The goodness of fit of the mathematical model for the analytical standard uncertainty was verified using results from control samples.
Traceability (.f trac)
Random effects associated with the preparation of calibration standards are included in the analytical standard deviation. Hence, only effects causing covariance between measurement results are evaluated here. The expression for calculation of the concentration of the standards is:
where Cst is the mass concentration of ethanol in calibration standard, Wethanol is the weight fraction of ethanol in the calibrator, metha~ is the amount of calibrator that is weighted off, mtotal is the mass of the calibration standard after dilution, and dst is the density of the calibration standard. Information about the uncertainty of the value of the calibrator (Wethano 1) was obtained from the analytical certificate, the estimate of the standard uncertainty of weighing was based on the specifications of the analytical balance, and the standard uncertainty of the density of the solution was calculated from experimental data. The relative standard uncertainty was expressed as follows (1,9):
Values for Wethano, and dst were 0.9413 and 1.008 g/cm 3 with standard uncertainties U(Wethanol) and u(dst) 0.005 and 0.002 g/cm 3, respectively. The mass of calibrator (methanol) and mass of standard (mtotal) depends on the standard, but typical values of methano I is in the range 0.1-1.5 g, and the value of mtota I is around 500 g. The standard uncertainties U(methanol) and u(mtotal) were both 0.0012 g. Using these values the relative combined standard uncertainty of ftrac was calculated using Equation 8, yielding 1.0%, 0.42%, 0.21%, 0.18%, 0.16%, and 0.13% at the ethanol concentrations 0.2, 0.5, 1.2, 1.5, 2, and 3 g/kg. This uncertainty budget for ftrac does not include the uncertainty due to "salting-out" effects. According to (14) the saltingout effect is eliminated by diluting blood 1:10. Hence, we assume that the uncertainty contribution from salting-out effects is so small that it can be ignored.
The density of blood (fdem)
To estimate the biological variability in the actual density of blood, the density was expressed in terms of the water content of blood (weight/weight fraction, Xw):
Eq. 9
In this equation, dw = 1.000 g/cm 3 is the density of water and dsolids is the density of solids in the blood. Assuming an approximately constant composition of solids in fresh as well as in postmortem blood, the value of dsolid~ can be estimated at the average density dblood = 1.055 g/cm 3 using an average water content -~w = 0.788 (15) . Inserting these values into Eq. 9, and isolating dsolids , yields dsolids = 1.326 g/cm 3. Rearranging Eq. 9 and using the mentioned values for d~ and dsolids one arrives to the following expression for dblood: dw' dsolids 1.326g 9 cm -3 dbl~176 = X w 9 dsolids +(1 -Xw)" dw -1 + Xw" 0.326
Eq. 10
Hence, the correction factor fdens can be expressed as the ratio between the average and actual blood density: The biological variation ofxw can be found in the literature. Table I summarizes some findings for fresh blood (15) , and for blood sampled in average 2 h and 100 h postmortem (16) . In reference (15), the standard deviation of the blood water content was calculated for both men and women. The value of U(Xw) in Table I is the pooled estimate of this "within-gender" standard deviation combined with the between-gender standard variation.
Based on Eq. 11, the standard uncertainty of fdens Was now expressed as a function of the standard uncertainty Of Xw:
TXw/ " u2(Xw) = Eq. 12
1.055 1.32----6 ' 0.326" U(Xw) = 0.259' U(Xw)
Hence, u(fdens)/fdens is estimated from the above expression by inserting the values of U(Xw) from Table I and dividing by fdens (assumed to be equal to one). The estimates are 0.39%, 0.99%, and 1.26% for fresh blood, 2 h postmortem, and 100 h postmortem blood, respectively.
Water fraction effect ffw)
The expression for f~ depends on the blood water fraction Xw. First, the gas phase concentration of ethanol is proportional to the concentration in the aqueous phase:
Eq. 13
In Eq. 13, C(g) and Cw are the gas phase and water phase concentrations, respectively, and K is the Henry constant. Headspace sampling is done on a blood sample diluted 1:11. Hence, the ethanol concentration in the aqueous phase can be expressed by the volumes used in the dilution:
Vblood Vblood Cw = Cbl~176 " V w + Vdi I -Cbl~176 " V w + 10" Vbloo d
Eq. 14 In this expression, Vw, Vblood, and Vdi I (= 10 X Vblood) is the volume of the blood sample's water fraction, the volume of the blood sample, and the volume of the diluent added to dilute the blood sample, respectively, and Cblood is the blood alcohol concentration. Because, this expression can be inserted into Eq. 14 and Vblood eliminated:
Eq. 15
X( w) 10
Inserting this expression into Eq. 13 yields:
Ctgl xw [ dw !
The correction factor fh is equal to the ratio between the actual gas phase concentration and the gas phase concentration at the average water content, that is: 
I I § l o dw
It was assumed that dblood had a constant value of 1.055 g/cm a. Using the above expression, the relative standard uncertainty, u(fw)/fw was estimated to be 0.15%, 0.37%, and 0.47% for fresh blood, 2 h postmortem, and 100 h postmortem blood, respectively.
The covariance between fdens and fw
According to GUM (1), the covariance between fdens and fh due to their dependence on the water fraction x~ is given by the expression: Inserting the values of U(Xw) from Table I gives estimates of the relative covariance of 5.66 x 10 4, 3.70 x 10 -5, and 5.91 x I0 -s for fresh blood, 2 h postmortem blood, and 100 h postmortem blood, respectively.
U(fdens,
fw
Combination of all water content related terms
As described in the Experimental section, all water related uncertainty components, that is, u(fden~)/fdens, u(fw)/fw, and U (fdens, (fw) , can be combined in the term UBWC. Values ca]cufdens "fw lated for UBWC are presented in Table II . Also shown are values of the respective correction factors calculated using the values of the average blood water contents in Table I .
Combined standard uncertainty
In Table III are presented estimates of the relative standard uncertainties of, c, ftrac, and UBWC for fresh blood, blood sampled approximately 2 h postmortem, and blood sampled approximately 100 h postmortem (16) . Input values were obtained using Eq. 6, and input values for UBWC were from Table II. The relative standard uncertainties were combined using Eq. 3b with n = 2. The relative combined standard uncertainty and the combined standard uncertainty are likewise presented in Table III .
The contribution of each uncertainty component to the combined variance was estimated and results are presented in Figure 2 . The contribution was calculated as (2) (relative combined standard uncertainty) 2
where the relative standard uncertainty of the component xi and the relative combined standard uncertainty is found in Table III. The uncertainty budget for different numbers of replicates (n = 2-4) is presented in Figure 3 . The combined standard uncertainty in Figure 3 was calculated by multiplying the relative combined standard uncertainty estimated by Eq. 3b with BAC. The figure also indicates the requirements to the combined standard uncertainty when using a "safety margin" d = 0.1 g/kg. The requirement to the standard uncertainty is calculated for three different levels of acceptable risk of making a type 1 error using Eq. 5. For comparison, the standard uncertainty forn = 2 for measurements made on 2 h and 100 h postmortem blood samples are also shown. The concentration 2.00 g/kg represents an important legal limit in Denmark. In order to investigate the range of values that might be assigned to a sample with that concentration the distribution of results of measurements were modelled as a Gaussian distribution with mean equal to 2.00 g/kg and standard deviation 0.0318 g/kg. The distribution of measurement results is shown in Figure 4 .
Discussion
Analytical uncertainty
For measurements made on fresh blood, the dominating uncertainty component was the analytical variation. It accounted for approximately 90% of the variance (Figure 2) . As illustrated in Figure 3 , when the combined standard uncertainty is dominated by the analytical uncertainty, it can be efficiently reduced by increasing the number of replicates. The combined standard uncertainty is reduced by approximately 16% and 26% by going from two to three and then four replicates, respectively.
Biological variation
We identified two biologically related uncertainty components: First, the use of a constant value for the density of blood is a source of uncertainty, since the actual density of the blood sample will vary between different persons. The relative standard uncertainty on this density correction was small for fresh blood samples, 0.39%, but was significant compared to the analytical relative standard uncertainty in postmortem blood, namely 0.99% and 1.26%, for 2 h and 100 h postmortem blood. This was expected as the variation in the blood water content increases quite significantly after death (Table I) . Second, the matrix difference between aqueous calibration samples and blood also contributes with uncertainty, because Figure 3 . Combined standard uncertainty u(BAC) of measurement results of ethanol in blood (fresh or 100 h postmortem samples) as the function of the concentration (BAC) and the number of replicates (n). Limits for u(BAC) were calculated using Eq. 5, with d= 0.1 g/kg and a = 0.1%, 1%, and 5%, respectively. 15% 10% 5% 0% ethanol is dissolved in the aqueous fraction of blood, and "excluded" from the solid fraction. We found that this uncertainty component was small in both fresh blood and postmortem blood (< 0.5%).
The relative combined standard uncertainty of all three blood water content related components (that is, fdens, fw and their covariance) was calculated and presented in Table II as UBwc. The large biological variation in blood water content in postmortem blood compared to blood from living persons means that the combined standard uncertainty of this uncertainty component is 2.5-3 times larger when measuring ethanol in postmortem blood compared to measuring in fresh blood. However, this does not mean that the differences in the combined standard uncertainty of the result of measurement are just as dramatic.
As can be seen in Table III and Figure 2 , Uswc is a minor uncertainty component when measuring ethanol in fresh blood, but significant when measuring ethanol in post-mortem blood samples. For blood sampled approximately 100 hr post-mortem, UBwc is the largest contributor to uncertainty in the ethanol concentration range of 1.2-2 g/kg ( Figure 2C ). As a result, the combined standard uncertainty of measurements on postmortem blood is only 20-40% larger than the combined standard uncertainty when measuring ethanol in fresh blood (Table III, Figure 3 ). Moreover, because the blood water content of 100 postmortem blood is so much different from that of fresh blood, the correction factors (fdens and fw ) needed to correct for the bias caused by this can no longer be neglected (Table II) . Hence, the uncertainty budget for 100 h postmortem blood samples is valid only if a correction factor of 0.983 (=f&ns x fw) has been applied.
Uncertainty from traceability
The traceability constituted only a minor fraction of the variance (_< approximately 4%) (Figure 2 ). This is expected, since the calibration standards are prepared from an aqueous solution of the pure compound involving only weighing and dilutions, and because ethanol is a well-defined and stable chemical.
Combined standard uncertainty
When measuring fresh blood, the relative combined standard uncertainty is in the order of 1.6% in the middle of the concentration range (1.2-2.0 g/kg) and increases to approximately 5% at 0.2 g/kg. It also increases slightly in the range of 2.0 to 3.0 g/kg because of an increase in the analytical relative standard uncertainty (Table III) . Whether this is a real effect or due to an inadequacy of the mathematical model of the analytical standard uncertainty at high concentration levels is not clear at present. The relative combined standard uncertainty of measurements on postmortem blood is somewhat higher, approximately 2.3% in the range of 1.2-2 g/kg (Table III) . Figure  4 illustrates the distribution of possible measurement results on a sample with a true concentration 2.00 g/kg. If the legal limit is 2.00 g/kg, half of the measurement results will exceed this limit because of the uncertainty of the measurement. However, very few results exceed 2.1 g/kg, hence, a subtraction of 0.1 g/kg from the result is sufficient in most cases to avoid erroneously concluding that the limit is exceeded when in fact it is not. Figure 3 illustrates this in a more quantitative manner: for
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Journal of Analytical Toxicology, Vol. 28, September 2004 fresh blood measurements, the probability of committing a type 1 error is less than 0.1% with a safety margin of 0.1 g/kg, at least up to a concentration level of 2.00 g/kg (assuming n = 2). However, the protection by this safety margin is less for postmortem blood samples. At 2.00 g/kg the combined standard uncertainty is 0.0457 g/kg for 100 h postmortem samples. Using Eq. 4, the probability of making a type 1 error is calculated to be less than 1.4%. It should be emphasized that only the combined standard uncertainty should be used to establish such safety margins. The analytical uncertainty is a part of the combined standard uncertainty of measurement; hence, basing the safety margin on the analytical uncertainty alone will overestimate the safety provided by it. However, for the ethanol measurements on fresh blood the difference would be negligible because the combined standard uncertainty is dominated by the analytical uncertainty.
Lastly, we have deliberately omitted the sampling aspect of the measurement. Ethanol levels in blood may change after sampling. Sodium fluoride is added to blood sampling vials to avoid biological production or consumption of ethanol (17) . When collecting blood postmortem, the site of sampling could be important for the result. For example, in a study of the difference between duplicate samples, a standard deviation of 0.14 g/kg (n = 34) was observed for duplicate samples collected at the same site, while the standard deviation was 0.25 g/kg (n = 33) for duplicate samples collected at different sites (but at the same time of collection) (18) . These data indicate that sampling of postmortem blood could be a much larger uncertainty component than any of the components considered in the budget presented in this article.
Conclusions
We have illustrated two uses of an uncertainty budget for the measurement of ethanol in blood by headspace GC. First, it allows identification of the most significant uncertainty component of the analytical method, and hence it indicates a way of reducing the combined standard uncertainty of measurement. Second, it allows one to judge if the method fulfils specified performance criteria. In the example presented, the performance criteria arise from the desire to apply a safety margin to the analytical results. Both of these needs were met by evaluating the uncertainty in an uncertainty budget. The analytical variation was the largest uncertainty component when measuring ethanol concentrations in fresh blood, accounting for more than 90% of the variance. However, for postmortem samples, the variation in blood water content was an additional significant uncertainty component, which was even larger than the analytical uncertainty at some concentration levels.
